According to the international classification in effect until last year, symptomatic or secondary epilepsy, caused by damage to brain structures, idiopathic, primary (an independent, presumably hereditary disease) and cryptogenic epilepsy were distinguished.
Modern research has shown that polytherapy with several drugs in small doses has not justified itself. The drug is selected strictly in accordance with the type of epilepsy and the type of epileptic seizure.
Without taking into account pathogenetic factors, many continue to call it neuritis, and ICD-10, based on the anatomical and topographic features of the disease, classifies it as a mononeuropathies of the upper extremities with the code G56.0-G56.1.
This is not a disease, but a whole complex of pathological and physiologically inadequate reactions of the brain to various environmental factors. The person experiences discomfort.
Its numerous transformations are possible, as well as functional changes. Myelin fibers and axial cylinders are also subject to change. It is a serious problem that modern neurology increasingly faces.
Among the numerous types of epilepsy – a chronic disorder of the central nervous system with paroxysmal manifestation of symptoms – temporal epilepsy stands out, in which epileptogenic zones or areas of local attachment of epileptic activity are located in the temporal lobes of the brain.